152 related articles for article (PubMed ID: 25446377)
1. Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
Cavaliere V; Lombardo T; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA
Eur J Cancer; 2014 Dec; 50(18):3243-61. PubMed ID: 25446377
[TBL] [Abstract][Full Text] [Related]
2. Regulated Cell Death of Lymphoma Cells after Graded Mitochondrial Damage is Differentially Affected by Drugs Targeting Cell Stress Responses.
Lombardo T; Folgar MG; Salaverry L; Rey-Roldán E; Alvarez EM; Carreras MC; Kornblihtt L; Blanco GA
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):489-500. PubMed ID: 29205851
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
[TBL] [Abstract][Full Text] [Related]
4. Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion.
Lombardo T; Cavaliere V; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA
Toxicol Appl Pharmacol; 2012 Feb; 258(3):351-66. PubMed ID: 22178740
[TBL] [Abstract][Full Text] [Related]
5. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines.
Peng CY; Jiang J; Zheng HT; Liu XS
Leuk Lymphoma; 2010 Feb; 51(2):297-303. PubMed ID: 20038232
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces autophagy and antitumor effects in Burkitt's lymphoma Raji cells.
Li CL; Wei HL; Chen J; Wang B; Xie B; Fan LL; Li LJ
Oncol Rep; 2014 Oct; 32(4):1557-63. PubMed ID: 25110043
[TBL] [Abstract][Full Text] [Related]
7. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death.
Park HK; Han BR; Park WH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325
[TBL] [Abstract][Full Text] [Related]
8. A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia.
Kornblihtt LI; Cabral Lorenzo MC; Gil Folgar ML; Minissale CJ; Malusardi C; Rojas F; Lombardo T; Blanco GA
Toxicol Appl Pharmacol; 2020 Jul; 398():115016. PubMed ID: 32325063
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
Kanzawa T; Zhang L; Xiao L; Germano IM; Kondo Y; Kondo S
Oncogene; 2005 Feb; 24(6):980-91. PubMed ID: 15592527
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
11. Activation of the ubiquitin-proteasome system against arsenic trioxide cardiotoxicity involves ubiquitin ligase Parkin for mitochondrial homeostasis.
Watanabe M; Funakoshi T; Unuma K; Aki T; Uemura K
Toxicology; 2014 Aug; 322():43-50. PubMed ID: 24801902
[TBL] [Abstract][Full Text] [Related]
12. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
13. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
Xiao G; Tang X; Yao C; Wang C
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114
[TBL] [Abstract][Full Text] [Related]
15. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation.
Ji MM; Wang L; Zhan Q; Xue W; Zhao Y; Zhao X; Xu PP; Shen Y; Liu H; Janin A; Cheng S; Zhao WL
Autophagy; 2015; 11(12):2160-71. PubMed ID: 26735433
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
18. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
19. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
20. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
